Traditionally, biopharma companies can increase their revenue for research and overhead through price increases for exclusively owned products. (First, raise the price on drugs you’ve got a patent for.... read more →
The biopharma industry is one in which successful companies, investors, drug developers, and scientists can manage – even celebrate – the inevitable failures of research and development. In a... read more →